Effects of Tamoxifen on Normal Breast Tissue
Author Information
Author(s): K.J. Walker, J.M. Price-Thomas, W. Candlish, R.I. Nicholson
Primary Institution: Tenovus Institute for Cancer Research, University of Wales College of Medicine
Hypothesis
Tamoxifen therapy influences the expression of hormone receptors in normal breast tissue.
Conclusion
Tamoxifen does not adversely affect normal breast tissue and does not stimulate cell proliferation.
Supporting Evidence
- Tamoxifen did not influence the expression of PgR, EGFR, or Ki67 in cancer-associated normal tissue.
- A significant increase in ER positivity was observed in ductal tissue after tamoxifen treatment.
- Ki67 expression was observed in less than 10% of all normal cells and was suppressed by menopause.
Takeaway
This study looked at how tamoxifen, a medicine for breast cancer, affects normal breast tissue. It found that tamoxifen doesn't make the cells grow faster, which is good news for women taking it to prevent cancer.
Methodology
Immunohistochemical assays were used to study the expression of hormone receptors in normal breast tissue samples.
Limitations
The study primarily involved postmenopausal women, limiting the generalizability of the findings to other populations.
Participant Demographics
The study included 76 normal breast tissue samples from women, with a mix of pre and postmenopausal status.
Statistical Information
P-Value
P = 0.02 for ER positivity in lobules; P = 0.04 for PgR in ducts.
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website